Science & Technology | Israeli Innovation

14 of 16 severe COVID patients in trial recover with experimental Israeli drug

2 cases remain in critical condition 28 days after receiving Enlivex Therapeutics' Allocetra therapy in Phase II trials, marking 0% mortality rate in both studies of treatment